The Institute for Innovation & Valuation in Health Care, InnoValHC, is an independent not-for-profit research organization. It was established by scientists with medical, health economic, and econometric backgrounds, as well as hands-on management experience, to analyze the economic dimension of health and health care, including research into the normative foundations and the methods of health economics, applied cost of illness and cost benefit studies, and their use in Health Technology Assessment (HTA).
German Cancer Congress (DKK) 2026
Michael Schlander was invited to contribute to the Highlight Session ´Socioeconomic Consequences of Cancer in Germany: The Perspective of Patients and their Relatives´ at the DKK in Berlin / Germany (Feb. 21, 2026).
Financing Health Care: Structural Challenges in Germany
Forthcoming article by Michael Schlander on structural challenges in health care financing and necessary reforms in the German health care system.
Read more … Financing Health Care: Structural Challenges in Germany
Heidelberg Health Economics Summer School 2025
The Heidelberg Health Economics Summer School took place in the picturesque setting of the Italian Dolomites (Basic Program / Bruneck-Brunico, Sept. 11-13, 2025).
Pharma Pricing & Access Innovation Conference 2025
Michael Schlander spoke about ´Early Strategic Decision Making in Drug Development: The Role of Health Economics for Market Access´ at the PPIC in Basel / Switzerland (June 3-5, 2025).
Read more … Pharma Pricing & Access Innovation Conference 2025
